期刊文献+

PTEN蛋白在前列腺癌组织中的表达及其临床意义 被引量:3

Expression of PTEN in Prostate Cancer and its Significance
下载PDF
导出
摘要 目的 探讨PTEN蛋白在前列腺癌组织中的表达及其临床意义。方法 应用免疫组织化学S -P方法 ,检测 42例前列腺癌及 2例正常前列腺组织和 5例良性前列腺增生组织中PTEN蛋白的表达。结果  42例前列腺癌组织中 11例 (2 6.2 % )PTEN蛋白表达阳性。随肿瘤细胞病理分级、临床分期的增高 ,PTEN蛋白阳性表达率降低 ,高、中分化组 2 2例中 10例 (4 5 .5 % )PTEN表达阳性 ,低分化组 2 0例中 1例 (5 .0 % )阳性表达 ;A +B期和C +D期前列腺癌组织中的阳性表达率分别为 3 4.5 % (10 /2 9)和 7.7% (1/13 ) ,各组间比较有显著性差异 (χ2 =8.87,P <0 .0 1;χ2 =4.0 3 ,P <0 .0 5 ) ,正常前列腺组织和良性前列腺增生组织中PTEN蛋白均呈阳性表达。结论 PTEN蛋白异常表达在前列腺癌的进展中有重要作用 。 Objective To investigate the expression of PTEN in primary prostate cancer and its clinical significance.Methods PTEN protein expression of 42 prostate cancer,2 normal prostate tissue and 5 benign prostatic hyptertrophy sample were analysed by immunohisochemical staining.Results The positive rate of PTEN was 26.2%(11/42) in primary prostate cancer.The higher the grade and the clinical stage of tumor were,the lower the expression of PTEN.The positive rate of PTEN in well or moderately differentiated type and in poorly differentiated type were 45.5%(10/22) and 5.0%(1/20)(χ 2=8.87,P<0.01) respectively.The positive rates of PENT in A+B stage and in C+D stage were 34.5%(10/29) and 7.7%(1/13)(χ 2=4.03,P<0.05) respectively.But 7 cases with normal and benign lesions all had positive expression of PENT.Conclusion The abnormal expression of PTEN may play an important role in the development of primary prostate cancer.PENT examination is useful for the judgement of tumor development and prognosis.
机构地区 解放军第
出处 《实用癌症杂志》 2003年第4期368-370,共3页 The Practical Journal of Cancer
关键词 前列腺癌 PTEN蛋白 免疫组织化学 病理分级 预后 Prostate neoplasms Carcinoma PTEN protein Iummunohistochemistry
  • 相关文献

参考文献13

  • 1彭杰青 中山医科大学病理学教研室 同济医科大学病理学教研室编著.前列腺肿瘤[A].中山医科大学病理学教研室、同济医科大学病理学教研室编著.外科病理学(下册) 第2版[C].武汉:湖北科学技术出版社,1999.736.
  • 2乔建勇,付宪文,焦保华,张祥宏,段庆华.PTEN和钙粘素在胶质瘤中的表达及临床意义[J].中华神经外科杂志,2002,18(4):246-248. 被引量:5
  • 3McMenumin ME, Soung P, Perera S, et al. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage[J]. Cancer Res, 1999,59(17):4291.
  • 4Steck PA, Pershous MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, atchromosome 10q23.3 that is mutated in multiple advanced cancers[J]. Nat Genet, 1997,15(4) :356.
  • 5Fleming ID,Cooper JS, Henson DE,et al. eds, American Joint Committee on Cancer, Manual for Staging of Cancer, 5th ed [M]. Lippincott Philadelphia, 1997: 220.
  • 6Tamura M, Gu J, Matsumoto K, et al. Inhibition of cell migration, spreading, and focal adhesion by tumor suppressor PTEN[J]. Science, 1998,280(5539) : 1614.
  • 7Li J,Yen C, Liaw D,et al. PTEN ,a putative protein tyrosine phosphatase genemutated in human brain, breast,and prostate cancer[J]. Science, 1997,275(5308): 1943.
  • 8Davies MA,Koul D, Dhesi H,et al. Regulation of AKT/PKB action, cellular growth, and apoptosis in prostate carcinomacells by MMAC/PTEN[J]. Cancer Res, 1999,59(11) :2551.
  • 9Lin H, Bondy ML, Langford LA, et al. Allelic deletion analyses of MMAC//PTEN and DMBT1 loci in gliomas:relationship to significance[J]. Clin Cancer Res, 1998,4(10) : 2447.
  • 10Rubin MA, Gerstein A, Reid K, et al. 10q23.3 loss of heterozygosity is higher in lymph node-positive(pT2-3,N + ) versus lymph node-negative(pT2~3, N0) prostate cancer[J], Hum Pathol, 2000,31(4) : 504.

二级参考文献1

共引文献4

同被引文献49

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部